Guidelines available for download on this website are for information purposes only and are not intended to inform any individual clinical decisions. STSTN and its members do not accept any responsibility for outcome of clinical decisions made as a result of reading these guidelines. All guidelines have been peer-reviewed and agreed to be published by the relevant lead consultants in the network.
The following guidelines relate to Paediatrics with sickle cell disease and thalassaemia:
Hydroxyurea (Hydroxycarbamide) – Paeds Guidelines *NEW 2018/19*
http://ukts.org/standards/ Thalassaemia Standards *NEW* 2018/19